Katherine Minson, MD

Katherine Minson, MD is a board-certified pediatric hematologist-oncologist and Senior
Medical Director at NovaBridge Biosciences with experience in academic clinical
research and preclinical drug development. She received her MD from the Medical
University of South Carolina, completed a pediatric residency at Vanderbilt University,
and her subspecialty training at the University of Colorado Denver. After completion of
fellowship, she served on the faculty at Emory University for four years. During this time,
she maintained a clinical practice focused on the care of children with cancer and blood
disorders, including benign hematology, solid tumors, hematologic malignancies,
immunohematology, and bone marrow transplant.

Dr. Minson also spent six years as a basic/translational researcher focused on pre-
clinical drug development of small molecule tyrosine kinase inhibitors (TKIs) of the TAM
(TYRO3/AXL/MERTK) family. Her preclinical work formed the basis for IND-approval of
a molecule currently in phase I clinical trials. Prior to transitioning to industry her focus
was on identification of resistance networks and combination TKI therapy.

She joined NovaBridge from Parexel International, where she most recently served as
Senior Medical Director and Therapeutic Area Lead for Gastrointestinal Cancers,
overseeing global programs from Phase I to III and mentoring a global team of medical